Alexander Cherkassky is a Wayland, Massachusetts-based life sciences professional who serves as the senior director and franchise head of Fluidigm Inc, positions he has held since 2018. In conjunction with working with the marketing and sales departments, Alexander Cherkassky is responsible for commercial growth initiatives, overseeing clinical research, and other duties.
Before joining the firm, Mr. Cherkassky served as the platform director for Thermo Fisher Scientific, a Waltham, Massachusetts-based firm where he oversaw mass spectrometry clinical and medical devices. As such, he was responsible for leading the product development team, alongside managing key clinical accounts.
Mr. Cherkassky also served as a scientific support director with the company between 2013 and 2016. He also holds experience with Perkinelmer, which he first joined in 1997, as an R&D director, principal scientist, technical leader, and scientist.
In addition, Alexander Cherkassky is a member of several professional organizations, such as Mass Spectrometry: Applications to the Clinical Lab, the American Chemical Society, and the American Association for Clinical Chemistry.